How GLP-1s compare to other treatments Compared with other medications for obesity and diabetes, GLP-1s deliver strong benefits
Abbreviations DPP: Diabetes prevention program DPPOS: Diabetes prevention program outcomes study GIP: Glucose-dependent insulinotropic polypeptide GLP-1RA: Glucagon-like peptide-1 receptor agonist MACE: Major adverse cardiovascular events NTS: Nucleus tractus solitary ORCVD: Obesity-related cardiovascular disease SCALE: Satiety and clinical adiposity liraglutide evidence STEP: Semaglutide treatment effect in people with obesity References Gonzlez-Muniesa P, Mrtinez-Gonzlez MA, Hu FB, et al
Finally, we could provide only three different plausible mechanisms involved in the regain of weight after the discontinuation of GLP-1RAs, and there could be many that need to be further interrogated
Rapid weight loss can lead to changes in the body's composition, including skin elasticity, muscle tone, and body proportions
, Solgar -
Although the antimicrobial ability of Au NPs is weaker than that of Ag NPs, the Au NPs have their own advantages
